Prevalence of spontaneous bacterial peritonitis in liver cirrhosis with ascites

Prevalence of spontaneous bacterial peritonitis in liver cirrhosis with ascites

 

Akande Oladimeji Ajayi^1,&, Patrick Temi Adegun², Ebenezer Adekunle Ajayi¹, Hassan Taiwo Raimi¹, Samuel Ayokunle Dada¹

 

¹Department of Medicine, Ekiti State University Teaching Hospital, P.M.B 5355, Ado Ekiti, Nigeria, ²Department of Surgery, Ekiti State University Teaching Hospital, P.M.B 5355, Ado Ekiti, Nigeria

 

 

^&Corresponding author
Ajayi Akande Oladimeji, Department of Medicine, Ekiti State University Teaching Hospital, P.M.B 5355, Ado Ekiti, Nigeria

 

 

 

 

Spontaneous bacterial peritonitis (SBP) is a very common bacterial infection in patients with cirrhosis and ascites requiring prompt recognition and treatment [1- 3]. It was first described by Conn and Fessel in 1971 as a syndrome of infected ascitic fluid in patients with hepatic cirrhosis, which they named SBP [4]. SBP is by definition an infection of previously sterile ascitic fluid, without any apparent intra-abdominal source of infection [5]. The infecting organisms are usually those found among the normal intestinal flora. When first described, its mortality exceeded 90% but it has been reduced to approximately 20% with early diagnosis and treatment [6 - 7].

All patients with cirrhosis and ascites are at risk of SBP and the prevalence of SBP in outpatients is 1.5-3.5% and about 10%-30% in hospitalized patients [8 - 9]. Half of the episodes of SBP are present at the time of hospital admission while the rest are acquired during hospitalization [1]. In-hospital mortality for the first episode of SBP ranges from 10% to 50%, depending on various risk factors [10 - 11]. One-year mortality after a first episode of SBP has been reported to be 31% and 93% [12].

The pathophysiology of SBP is not completely understood. Translocation of bacteria and endotoxins from the gastrointestinal tract to peritoneal fluid is believed to be a key mechanism behind the development of SBP, and is facilitated by impaired defensive mechanisms in cirrhotic patients [13 - 17]. Proteins of the complement cascade have lower levels in cirrhotic patients and the opsonic and phagocytic properties of neutrophils are decreased in patients with cirrhosis. Bacteremia from the urine or the respiratory tract can also lead to infection of the ascitic fluid. SBP may also be iatrogenic [18], such as after endoscopic treatment of esophageal or gastric varices.

Patients with SBP may have one of the following [1,8]: (1) local symptoms and/or signs of peritonitis: abdominal pain, abdominal tenderness, vomiting, diarrhea, ileus; (2) signs of systemic inflammation: hyper or hypothermia, chills, altered white blood cell count, tachycardia, and/or tachypnea; (3) worsening of liver function; (4) hepatic encephalopathy; (5) shock; (6) renal failure; and (7) gastrointestinal bleeding. However, it is important to point out that SBP may be asymptomatic in about 10-32% of cases, particularly in outpatients [8, 19 - 21]. Nigerian data is very scanty regarding the prevalence of SBP in patients with liver cirrhosis and ascites. The aim of this study was to determine the prevalence and characteristics of SBP among in-patients with cirrhosis and ascites seen at our facility and to compare the results with studies elsewhere.

 

 

Thirty one patients with liver cirrhosis and ascites who were admitted into the Medical ward of the Ekiti State University Teaching Hospital (EKSUTH), Ado-Ekiti, Nigeria from August 2009 to July 2010 were retrospectively studied. The diagnosis of liver cirrhosis was established on the basis of clinical evaluation, biochemical parameters, abdominal ultrasounds and viral markers. All the patients had abdominal paracentesis done within 48 hours of admission under aseptic condition. Ascitic fluid analysis was done that included absolute neutrophils count, culture sensitivity, ascitic albumin and cytology.

SBP was diagnosed using standard criteria, namely, an absolute neutrophil count of >250 cells/mm³ as determined by microscopy, that is neutrocytic ascites, in the absence of an intra-abdominal source of infection [1, 22]. If ascitic fluid cultures were positive and the neutrophil count was >250 cells/mm³, such patients were diagnosed as having culture- positive neutrocytic ascites or SBP. If ascitic fluid cultures were negative in the presence of neutrocytic ascites, these patients were characterized as having culture-negative neutrocytic ascites (CNNA). Patients with positive cultures on ascitic fluid but without neutrocytic ascites were classified as having monobacterial bacterascites (MNB).

An ethical clearance for this study was obtained from the EKSUTH Ethical and Research Committee. Data obtained were analyzed using the statistical package for social sciences (SPSS, version 15) statistical software.

 

 

The mean age of the studied population was 62±9 years (age range 43-78 years). Seventeen (54.8%) were males while fourteen (45.2%) were females giving a male to female ratio of 1.2:1. Fifteen (48.4%) were in the 41-60 age group while the remaining sixteen (51.6%) were in the 61-80 age group (Table 1). SBP developed in 21 (67.7%) of the patients. Of the 21 that developed SPB, culture positive SBP was present in 66.7% (14/21) while CNNA was found in 33.3% (7/21). The prevalence of MNB was 26% (8/31) in this study (Table 2).

Of those with SBP, 93% had monomicrobial infection with aerobic Gram negative bacilli being responsible in 66.7% of the cases with E.coli (70%) being the predominant organism followed by Klebsiella species. Gram positive organisms accounted for 33.3% with Streptococcal species (60%) being the predominant organism followed by Staphylococcus aureus (40%) (Table 3).

There was no gender difference in the occurrence of SBP. All the patients with SBP had ascitic fluid protein less than 1gm% (Figure 1). Majority (80%) of the patients with SBP were in Child's grade C, while the remaining 20% were in Child's grade B. Patients with SBP had significantly lower platelet count when compared with those without SBP, p < 0.05. Also, international normalization ratio (INR) was significantly higher in those patients with SBP compared with those without SBP, p < 0.05. The poor prognostic indicators found in this study were; low ascitic protein, hepatic encephalopathy, coagulopathy, renal dysfunction (creatinine >2mg/dl) and leukocytosis (all having p < 0.05).

 

 

Spontaneous bacterial peritonitis (SBP) is a potentially life-threatening complication in patients with cirrhosis and has typically been described in hospitalized patients. The prevalence of SBP in hospitalized patients with cirrhosis and ascites is between 10% and 30% [23-24]. The prevalence of SPB in our study was found to be 67.7%. This was high compared to 10-30% found by most studies from the west; Tandon P et al [7], Rimola A et al [8], Almdal TP et al [23] and Pinzello G et al [24]. This may be due the fact that majority of our patients presented in Child's grade C. The prevalence of CNNA (a variant of SPB) in this study was 33.3% and this was similar to that reported by Runyon et al [25].

The prevalence of MNB in this study was 26%, higher than the 11% prevalence reported by Chu CM et al [26]. Again this might be due to the late presentation of the patients to our health facility.

In approximately 50-60% of cases, the organism responsible is isolated in ascitic fluid or in blood cultures, the remaining are variants of SBP [27]. More than 92% cases of SBP are monomicrobial, with aerobic Gram- negative bacilli; being responsible for more than two- third of all cases with Escherichial coli being the most common followed by Klebsiella species [28]. Almost 25% were caused by Gram-positive organisms with Streptococcal species being the most common followed by Staphylococcus aureus. Anaerobe causes nearly 1% of SBP and monobacterial ascites [29]. Anaerobes were not found in our study as a cause of SBP.

About 93% of the patients in this study had monomicrobial infection with aerobic Gram negative bacilli being responsible in 66.7% of the cases and this was similar to that reported by Gills AS et al [30]. E.coli was the predominant organism (70%), followed by Klebsiella species. E.coli was also the predominant organism found in the studies of Gills et al [30]. In the study conducted in Khyber Teaching Hospital, Peshawar 2003, showed E. coli was isolated in 58.13%, Streptococcus pneumoniae in 18.60%, Staphylococcus aureus in 9.13%, Klebsiella in 9.13% and Acinectobacter in 4.63% [31]. Gram positive organisms accounted for 33.3% with Streptococcal species (60%) being the predominant organism followed by Staphylococcus aureus (40%). The clinical presentations found in this study were; fever (70%), abdominal pain (56%), encephalopathy (38%) and jaundice (23%). This was consistent with the findings of Runyon BA et al [28].

The poor prognostic indicators found in this study were; low ascitic protein, hepatic encephalopathy, coagulopathy, renal dysfunction (creatinine <2mg/dl) and leukocytosis (all having p < 0.05). Majority of those that presented in Child's grade C succumbed to the overwhelming infection, again stressing the need for early presentation and high index of suspicion among the caring physicians.

 

 

In view of the high prevalence and mortality rate of SBP in our study population, it is imperative that awareness campaign be vigourously pursued as regards early presentation to reduce the morbidity and mortality in this group of patients. It is equally recommended that diagnostic abdominal paracentesis for cell count and culture in any patient with onset of ascites or cirrhotic patients with ascites and suggestive symptoms compatible or suggestive of SBP be carried out.

 

 

The authors declare no competing interests.

 

 

Ajayi Akande Oladimeji: Designed the study, collected and analysed data, interpreted data, prepared and revised manuscript for final submission. Ajayi Ebenezer Adekunle: Substantial contribution to study design, collected and analysed data, interpreted data revised manuscript for submission. Adegun Patrick Temi: Collected and analysed data, interpreted data, revised manuscript for final submission. Raimi Hussen Taiwo: Collected data, prepared and revised manuscript for final submission. Dada Samuel Ayokunle: Collected data, prepared and revised manuscript for final submission. All the authors have read and approved the final version of the manuscript.

 

 

Table 1: Age and gender distribution of the study population

Table 2: Showing ascitic culture and neutrophil counts

Table 3: Showing bacteriology and culture of ascitic fluid

Figure 1: Showing the relationship between ascitic neutrophils and protein

 

 

1. Rimola A, Gracia-Tsao G, Navasa M, et al. Diagnosis, treatment and prophylaxis of spontaneous bacterial peritonitis: a consensus document. International Ascites Club. J Hepatol. 2000; 32(1):142-153. PubMed | Google Scholar


2. Caly WR, Strauss E. A prospective study of bacterial infections in patients with cirrhosis. J Hepatol. 1993; 18(3):353-358. PubMed | Google Scholar


3. Wong F, Bernardi M, Balk R, Christman B, Moreau R, Garcia-Tsao G, et al. Sepsis in cirrhosis: report on the 7th meeting of the International Ascites Club. Gut. 2005; 54(5):718-725. PubMed | Google Scholar


4. Conn HO, Fessel JM. Spontaneous bacterial peritonitis in cirrhosis: variations on a theme. Medicine. 1971; 50(3):161-197. PubMed | Google Scholar


5. Fernandez J, Bauer TM, Navasa M, Rodes J. Diagnosis, treatment, and prevention of spontaneous bacterial peritonitis. Best Pract Res Clin Gastroenterol. 2000; 14(6):975-990. PubMed | Google Scholar


6. Garcia-Tsao G. Current management of the complications of cirrhosis and portal hypertension: variceal hemorrhage, ascites, and spontaneous bacterial peritonitis. Gastroenterology. 2001;120(3):726-748. PubMed | Google Scholar


7. Tandon P, Garcia-Tsao G. Bacterial infections, sepsis, and multiorgan failure in cirrhosis. Semin Liver Dis. 2008;28(1):26-42. PubMed | Google Scholar


8. Rimola A, Soto R, Bory F, Arroyo V, Piera C, Rodes J. Reticuloendothelial system phagocytic activity in cirrhosis and its relation to bacterial infections and prognosis. Hepatology. 1984; 4(1):53-58. PubMed | Google Scholar


9. Fernandez J, Navasa M, Gomez J et al. Bacterial infections in cirrhosis: epidemiological changes with invasive proceduresand norfloxacin prophylaxis. Hepatology. 2000; 35(1): 140-148. PubMed | Google Scholar


10. Nobre SR, Cabral JE, Gomes JJ ET AL. In-hospital mortality in spontaneous bacterial peritonitis: a new predictive model. Eur J Gastroenterol Hepatol. 2008; 20(12): 1176-1181. PubMed | Google Scholar


11. Thuluvath PJ, Morss S, Thompson R. Spontaneous bacterial peritonitis - in-hospital mortality, predictors of survival, and health care costs from 1988 to 1998. Am J Gastroenterol. 2001; 96(4): 1232-1236. PubMed | Google Scholar


12. Silvian C, Besson I, Ingrand P, et al. Prognosis and long term recurrence of spontaneous bacterial peritonitis in cirrhosis. J Heptol. 1993; 19(1): 188-189. PubMed | Google Scholar


13. Bolognesi M, Merkel C, Bianco S, et al. Clinical significance of the evaluation of hepatic reticuloendothelial removal capacity in patients with cirrhosis. Hepatology. 1994; 19(3):628-634. PubMed | Google Scholar


14. Garcia-Tsao G, Lee FY, Barden GE, Cartun R, West AB. Bacterial translocation to mesenteric lymph nodes is increased in cirrhotic rats with ascites. Gastroenterology. 1995; 108(6):1835-1841. PubMed | Google Scholar


15. Caly WR, Strauss E. A prospective study of bacterial infections in patients with cirrhosis. J Hepatol. 1993; 18(3):353-358. PubMed | Google Scholar


16. Rolando N, Gimson A, Philpott-Howard J, et al. Infectious sequel after endoscopic sclerotherapy of esophageal varices: role of antibiotic prophylaxis. J Hepatol. 1993; 18(3):290-294. PubMed | Google Scholar


17. Caruntu F, Benea L. Spontaneous bacterial peritonitis: Pathogenesis, diagnosis, treatment. J Gastrointest Liver Dis. 2006;15(1):51-6. PubMed | Google Scholar


18. Runyon BA, Hoefs JC. Ascitic fluid analysis in the differentiation of spontaneous bacterial peritonitis from gastrointestinal perforation into ascitic fluid. Hepatology. 1984; 4(3): 447-450. PubMed | Google Scholar


19. Evans LT, Kim WR, Poterucha JJ, Kamath PS. Spontaneous bacterial peritonitis in asymptomatic outpatients with cirrhotic ascites. Hepatology. 2003;37(4):897-901. PubMed | Google Scholar


20. Nousbaum JB, Cadranel JF, Nahon P, Nguyen Khac E, Moreau R, Thévenot T, et al. Diagnostic accuracy of the Multistix 8 SG_ reagent strip in diagnosis of spontaneous bacterial peritonitis. Hepatology. 2007;45(5):1275-1281. PubMed | Google Scholar


21. Weist R, Krag A, Gerbes A. Spontaneous bacterial peritonitis: recent guidelines and beyond. Gut. 2012; 61(2): 297-310. PubMed | Google Scholar


22. European Association for the Study of the Liver (EASL). Clinical practice guidelines on the management of ascites, spontaneous bacterial peritonitis, and hepatorenal syndrome in cirrhosis. J Hepatol. 2010; 53(3):397-417. PubMed | Google Scholar


23. Almdal TP, Skinhoj P. Spontaneous bacterial peritonitis in cirrhosis. Incidence, diagnosis, and prognosis. Scand J Gastroenterol. 1987; 22(3):295- 300. PubMed | Google Scholar


24. Pinzello G, Simonetti RG, Craxi A, Di Piazza S, Spano C, Pagliaro L. Spontaneous bacterial peritonitis: a prospective investigation in predominantly nonalcoholic cirrhotic patients. Hepatology. 1983; 3(4):545-549. PubMed | Google Scholar


25. Runyon BA, Canawati HN, Akriviadis EA. Optimisation of ascitic fluid culture technique. Gastroenterology. 1988; 95(5): 1351-1355. PubMed | Google Scholar


26. Chu CM, Chang KY, Liaw YF. Prevalence and prognostic significance of bacterascites in cirrhosis with ascites. Dig Dis Sci. 1995;40(3):561-565.. PubMed | Google Scholar


27. Parsi MA, Atreja A, Nizar NZ. Spontaneous bacterial peritonitis: Recent data on incidence and treatment. Cleveland Clinic Journal of Medicine. 2004; 71(7):564-570. PubMed | Google Scholar


28. Runyon BA. Monomicrobial nonneutrocytic bacterascites: A variant of spontaneous bacterial peritonitis. Hepatology. 1990; 12(4 pt. 1):710-715. PubMed | Google Scholar


29. Garcia-Tsao G. Spontaneous bacterial peritonitis. Rev Gastroenterol Mex. 2005 Nov;70 Suppl 3:66-8. PubMed | Google Scholar


30. Gills AS, Singh A, Matreja PS, Chinna RS, Mahajan R, Chhina DK. Spontaneous bacterial peritonitis in liver chirrhosis: An Indian perspective. Euroasian J Hepato-Gastroenterol. 2012; 2(1): 14-19. PubMed | Google Scholar


31. Iqbal S, Iman N, Alam N. Incidence of spontaneous bacterial peritonitis in liver cirrhosis, the causative organism and antibiotic sensitivity. J Postgrad Med Inst. 2004; 18: 614-619. PubMed | Google Scholar